ERIN SHOATES: Open Payments
NPI 1962880294 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 108 payments from 37 companies in 2025. Trend: 2023 $1,538 · 2024 $5,315 · 2025 $2,252
Food & beverage: $2,252
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $260 |
| Regeneron Healthcare Solutions, Inc. | 10 | $232 |
| Janssen Biotech, Inc. | 12 | $209 |
| Merck Sharp & Dohme LLC | 10 | $175 |
| Daiichi Sankyo Inc. | 8 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $148 |
| Gilead Sciences, Inc. | 1 | $111 |
| Caris MPI, Inc. | 6 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| PFIZER INC. | 4 | $72 |
Products named: LIBTAYO, KEYTRUDA, RYBREVANT, KISQALI, Trodelvy, MI CANCER SEEK, ERLEADA, Enhertu.
Industry payments across TN — which companies pay providers there.
